Epiness Tablets (Epinastine Hydrochloride)

Adult dose

1. Asthma, urticaria, eczema/dermatitis, pruritus, prurigo, and pruritic psoriasis Adults: Administer 20 mg of epinastine hydrochloride orally once daily. Adjust the dose as appropriate according to symptoms. 2. Allergic rhinitis Adults: Administer 10～20 mg of this medication orally once daily. Adjust the dose as appropriate according to symptoms.

This medicine should not be used by individuals who have allergic reactions to this medicine or its ingredients. Additionally, since it contains lactose, it should not be administered to patients with lactose intolerance or certain genetic metabolic disorders. Patients with liver disease or those who have a history of liver disease should be cautious as the liver condition may worsen with the use of this medicine. If any allergic symptoms occur during the use of this medicine, such as rash, urticaria, or facial swelling, discontinue use immediately and consult a healthcare professional. Occasionally, neurological symptoms such as drowsiness, headache, and dizziness may occur, so caution is needed when driving or operating machinery. Gastrointestinal symptoms such as indigestion, nausea, and abdominal pain may occur, so it is advisable to report any abnormal symptoms. Regular liver function tests are important as abnormalities of liver function or jaundice may appear. Rarely, signs of kidney function abnormalities, cystitis, palpitations, and dyspnea may occur, so careful observation is necessary. Pregnant or breastfeeding women should use this medicine cautiously only when necessary, as its safety has not been established, and those who are breastfeeding should either avoid use or discontinue breastfeeding. Children and the elderly may have different bodily functions, so they should take this medicine according to a doctor's instructions, and the elderly should have their liver and kidney functions regularly checked. In case of overdose, cardiac abnormalities such as arrhythmia may occur, so caution is required, and if overdose is suspected, treatment should be sought immediately at a hospital. This medicine should be kept out of the reach of children and should not be transferred to another container for safety. Lastly, this medicine is not intended for rapid relief of asthma attacks, so asthma patients should continue with separate treatments, and if it is ineffective, long-term use should be avoided.

Allergic reactions (rash, hives, redness), itching, swelling (face, extremities, etc.), erythema accompanied by itching, drowsiness, lethargy, headache, dizziness, insomnia, nightmares, numbness, feeling of heaviness in the head, nausea, discomfort in the stomach, dry mouth, abdominal pain, loss of appetite, vomiting, feeling of heaviness in the stomach, feeling of fullness in the stomach, diarrhea, constipation, dry lips, abdominal bloating, stomatitis, liver function impairment (elevated AST, ALT, γ-GTP, ALP, LDH), jaundice, hepatitis, proteinuria, frequent urination, hematuria, urinary retention, palpitations, shortness of breath, difficulty in expectoration, nasal congestion, thrombocytopenia, leukocytosis, gynecomastia, breast enlargement, menstrual irregularities, flushing, bitter taste, taste disturbance, chest pain

This medicine should be stored in a tightly closed container to protect it from air and moisture. Additionally, it is advisable to keep the medicine at room temperature between 1°C and 30°C. This helps maintain the medicine's effectiveness and safety for use.

Appearance

White or pale yellow round film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle